Original Source(s)
Related Content
Sex Disparities May Persist in CF Despite Modulators
Review findings suggested female patients with cystic fibrosis may continue to experience worse pulmonary outcomes despite highly effective modulator therapy
May 22, 2026
-
6 min
FDA Expands Guselkumab Label in PsA
Phase 3b APEX findings support the addition of structural joint damage inhibition data to the prescribing information.
May 29, 2026
-
2 min
FDA OKs Linaclotide in Young Children
Phase 3 data expanded use of linaclotide 72 mcg in pediatric functional constipation.
May 27, 2026
-
2 min